20230109-cnfr-jpmorgan-prsn-all-sent GSK.pdf

1、9 January 2023Delivering growth for the decade and beyondEmma Walmsley,Chief Executive OfficerJ.P.Morgan Healthcare Conference,San Francisco2This presentation may contain forward-looking statements.Forward-looking statements give the Groups current expectations or forecasts of future events.An inves

2、tor can identifythese statements by the fact that they do not relate strictly to historical or current facts.They use words such as anticipate,estimate,expect,intend,will,project,plan,believe,target and other words and terms of similar meaning in connection with any discussion of future operating or

3、 financial performance.In particular,these include statements relating tofuture actions,prospective products or product approvals,future performance or results of current and anticipated products,sales efforts,expenses,the outcome of contingencies suchas legal proceedings,dividend payments and finan

4、cial results.Other than in accordance with its legal or regulatory obligations(including under the Market Abuse Regulations,UK Listing Rules and the Disclosure Guidance and Transparency Rulesof the Financial Conduct Authority),the Group undertakes no obligation to update any forward-looking statemen

5、ts,whether as a result of new information,future events or otherwise.Investors should,however,consult any additional disclosures that the Group may make in any documents which it publishes and/or files with the US Securities and ExchangeCommission(SEC).All investors,wherever located,should take note

6、 of these disclosures.Accordingly,no assurance can be given that any particular expectation will be met andinvestors are cautioned not to place undue reliance on the forward-looking statements.Forward-looking statements are subject to assumptions,inherent risks and uncertainties,many of which relate